Literature DB >> 9785473

SOCS: suppressors of cytokine signalling.

R Starr1, D J Hilton.   

Abstract

Regulation of many aspects of cell behaviour occurs through the interaction of cytokines with specific cell surface receptors, resulting in the activation of cytoplasmic signal transduction pathways. Although cellular responses to cytokines are tightly controlled, few molecules have been identified which are able to switch these signals off. The suppressors of cytokine signalling (SOCS) proteins are a new family of negative regulators of cytokine signal transduction. SOCS proteins contain a variable amino-terminal region, a central Src-homology 2 (SH2) domain and a novel conserved carboxy-terminal motif termed the SOCS box. The expression of SOCS proteins is induced by cytokine. Once expressed, SOCS downregulate JAK/STAT pathways and hence the biological response. Recent studies, primarily reliant on overexpression of proteins, indicate that SOCS may be involved in modulating additional pathways, suggesting that they may play a more general role in regulating cellular responses to cytokine. The analysis of knockout mice will clarify the physiological role of SOCS in regulating cytokine responsiveness. Mutations leading to the loss of SOCS activity may give rise to cytokine hyperresponsiveness and may contribute to the development of diseases such as diabetes and cancer. Small molecule effectors which modify SOCS function may potentially be useful therapeutics for the treatment of certain diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785473     DOI: 10.1016/s1357-2725(98)00067-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  19 in total

1.  JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Susan A Kadlubar; Kristina L Bondurant; Roger K Wolff
Journal:  Mol Carcinog       Date:  2011-11-28       Impact factor: 4.784

2.  Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes.

Authors:  Allison M Gaudy; Alicia H Clementi; Jean S Campbell; Alan V Smrcka; Robert A Mooney
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.

Authors:  Shusheng Che; Tingting Sun; Jianpeng Wang; Yingbin Jiao; Chao Wang; Qinghai Meng; Weiguo Qi; Zhiyong Yan
Journal:  Tumour Biol       Date:  2015-04-04

4.  Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.

Authors:  C J Auernhammer; C Bousquet; S Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

5.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

6.  Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.

Authors:  Juliana Xu; Renia Sylvester; Ann P Tighe; Siming Chen; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

7.  IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3.

Authors:  Avanti Desai; Mi-Yeon Jung; Ana Olivera; Alasdair M Gilfillan; Calman Prussin; Arnold S Kirshenbaum; Michael A Beaven; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2016-01-07       Impact factor: 10.793

8.  SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation.

Authors:  Yutaka Takahashi; Nick Carpino; James C Cross; Miguel Torres; Evan Parganas; James N Ihle
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

9.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.

Authors:  Feng Fang; Michael A Rycyzyn; Charles V Clevenger
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

10.  Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells.

Authors:  H Siavash; N G Nikitakis; J J Sauk
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.